mPhase Technologies Says Its New Drug Delivery System Could Prove Very Useful for Diabetics
CLIFTON, NJ / ACCESSWIRE / January 26, 2016 / mPhase Technologies, Inc. (OTC: XDSL) (http://www.mPhaseTech.com) said today that its new, patented Drug Delivery System could prove especially useful and efficacious for patients taking insulin for diabetes, according to Company research. Ronald A. Durando, the Company's Chairman, President and CEO, said mPhase Technologies' new invention automatically dispenses a pre-set dosage of a drug such as...
Read more









